09.04.2024

Local production of medicines covered 29% of drug sales in Romania in the first six months of 2024, an analysis by market research company Cegedim shows. more

07.05.2024

The most important investment project for pharmaceutical group Zentiva Romania in 2024 is to manufacture at its two plants in Bucharest medical drugs included in the parent company's portfolio. more

06.06.2024

Antibiotice Iasi, (ATB.RO) the largest Romanian-owned pharmaceutical producer, will receive EUR100 million in EU funding for the production of drugs such as antibiotics, for which there are no more

05.27.2024

The investment level planned by the six largest drug makers in the plants they have in Romania reaches RON350 million in the 2024-2025 period, in line with ZF calculations, as projects are starting to more

02.03.2023

Sales of over-the-counter (OTC) drugs reached RON6.7 billion (almost EUR1.4 billion) in 2022, up 23% from the previous year, data from market research company Cegedim show. more

03.03.2022

Dragos Damian, CEO of one of Romania’s major drug makers, Terapia Cluj, says the company plans to carry out investments worth EUR5.5-5.8 million in Romania. more

11.02.2021

Pharmaceutical manufacturer Biofarm (BIO.RO) has inaugurated a new pharmaceutical manufacturing and testing facility in capital Bucharest, which entailed an investment of over EUR35 million. more

06.11.2021

Pharmaceutical producer Antibiotice budgeted RON93 million investments for 2021, RON10 million more than in 2020, mainly to develop new facilities at its plant in Iasi. more

11.11.2020

Vetro Solutions, a distributor of veterinary drugs and services, on Wednesday said it is investing EUR4.5 million in a veterinary drug factory that will be built in Iasi until 2021. more

02.05.2020

The value of medicine sold in pharmacies and in hospitals amounted to RON17.82 billion at wholesale prices in 2019 , up 10.9% compared with 2018, according to an analysis by Cegedim Customer more

09.16.2019

more

09.06.2018

The pharmaceutical market doubled in ten years. Medicine consumption is rising at a rate of 10% a year and pharmacies are everywhere. The government provides EUR1.5 billion subsidies. Romanians bought more

09.13.2017

more

02.28.2017

The major international pharmaceutical companies, whose revenue in Romania is in the range of hundreds of millions of euros, have been withdrawing thousands of drugs from the market, including more

10.25.2016

The best-selling over the counter (OTC) drugs in Romania are Nurofen of Reckitt Benckiser, followed by Aspenter (Terapia Cluj), Parasinus (GlaxoSmithKline) and No-Spa (Sanofi), according to the data more

02.11.2016

Sales of pharmaceutical drugs fell by 4.7% to 11.7 billion lei (EUR2.6 billion) last year (January-December), according to market research company Cegedim Romania data. This is the first decline for more

09.23.2015

The decline in drug prices, the constant increase in the clawback tax and the lack of transparency about how it is managed are affecting the pharmaceutical market in Romania. more

05.26.2015

The clawback tax could drop to 5%, as prices of medicines are lowered, health Insurance House president Vasile Ciurchea said Tuesday. more

04.27.2015

The five largest pharmaceutical producers in Romania posted slight growth of merely 2% to 2 billion lei (EUR453 million) on a market that increased by almost 7% in 2014 and are bracing themselves for more

01.23.2015

Regional pharmacy chains operating in one or two counties of Romania have been gaining ground lately and have now come to directly compete with national ones, says Iulian Trandafir, general manager of more

01.07.2015

Romanian executive Adrian Vasiliu, appointed at the helm of drug wholesaler Europharm Distributie in early November 2014, after spending the previous five years in Africa working in consumer goods more

12.10.2014

In 2014, Swiss group Novartis registered a “modest” revenue increase in Romania amid a challenging year in the healthcare industry, estimates Elena Mitova, general manager of Novartis Pharma more

12.02.2014

Sales of generic drugs, which account for 28% of the overall drug market, reached RON3.3 billion in the first nine months of this year, with prescription drugs holding the biggest weight, of above more

11.17.2014

Retail sales (via pharmacies) are now at more than 60% of the total at the moment, because of a decision made to change the business model at the end of 2011, says Dan Ivan, general manager of more

10.28.2014

The number of retail pharmacies has doubled in Romania in the past decade, and the issue of pharmacy numbers is being discussed again this year, as the demographic criterion regulating it is due to more